{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T19:46:43Z","timestamp":1744400803667},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03493-4","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:38:00Z","timestamp":1722656280000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["New concept in selecting blue dye injection site effect on clinical outcome of early-stage breast cancer patients: a retrospective cohort"],"prefix":"10.1186","volume":"22","author":[{"given":"Pattanan","family":"Bongkodmas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voranaddha","family":"Vacharathit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhoowit","family":"Lerttiendamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sopark","family":"Manasnayakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasaya","family":"Tantiphlachiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuphat","family":"Vongwattanakit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattanan","family":"Treeratanapun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mawin","family":"Vongsaisuwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"3493_CR1","unstructured":"Center MSKC. About Your Sentinel Lymph Node Biopsy, in Memorial Sloan Kettering Cancer Center. 2023."},{"key":"3493_CR2","doi-asserted-by":"publisher","first-page":"p3415630","DOI":"10.1155\/2019\/3415630","volume":"2019","author":"NU Dogan","year":"2019","unstructured":"Dogan NU, et al. The basics of Sentinel Lymph Node Biopsy: anatomical and pathophysiological considerations and clinical aspects. J Oncol. 2019;2019:p3415630.","journal-title":"J Oncol"},{"issue":"3","key":"3493_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/jamaoncol.2017.4000","volume":"4","author":"AS Heerdt","year":"2018","unstructured":"Heerdt AS. Lymphatic mapping and Sentinel Lymph Node Biopsy for breast Cancer. JAMA Oncol. 2018;4(3):431\u2013431.","journal-title":"JAMA Oncol"},{"issue":"8","key":"3493_CR4","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1470-2045(13)70590-4","volume":"15","author":"M Ahmed","year":"2014","unstructured":"Ahmed M, Purushotham AD, Douek M. Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol. 2014;15(8):e351\u201362.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3493_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0960-9776(03)00024-9","volume":"12","author":"TM Allweis","year":"2003","unstructured":"Allweis TM, et al. Current controversies in sentinel lymph node biopsy for breast cancer. Breast. 2003;12(3):163\u201371.","journal-title":"Breast"},{"issue":"10","key":"3493_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.ejso.2014.07.041","volume":"40","author":"V Galimberti","year":"2014","unstructured":"Galimberti V, et al. Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease. Eur J Surg Oncol. 2014;40(10):1203\u20138.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3493_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0284185113493775","volume":"55","author":"G Caruso","year":"2014","unstructured":"Caruso G, et al. Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. Acta Radiol. 2014;55(1):39\u201344.","journal-title":"Acta Radiol"},{"issue":"1\u20132","key":"3493_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10555-011-9343-7","volume":"31","author":"J Engel","year":"2012","unstructured":"Engel J, Emeny RT, H\u00f6lzel D. Positive lymph nodes do not metastasize. Cancer Metastasis Rev. 2012;31(1\u20132):235\u201346.","journal-title":"Cancer Metastasis Rev"},{"key":"3493_CR9","doi-asserted-by":"crossref","unstructured":"Ferrucci M, Franceschini G, Douek M. New techniques for sentinel node biopsy in breast cancer. Translational Cancer Res, 2018: p. S405\u201317.","DOI":"10.21037\/tcr.2018.02.07"},{"issue":"10","key":"3493_CR10","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3493_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/030089160008600411","volume":"86","author":"P Bianchi","year":"2000","unstructured":"Bianchi P, et al. Different sites and modes of Tracer Injection for Mapping the Sentinel Lymph Node in patients with breast Cancer. Tumori J. 2000;86(4):307\u20138.","journal-title":"Tumori J"},{"issue":"4","key":"3493_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595\u2013600.","journal-title":"Ann Surg"},{"issue":"5","key":"3493_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000491703","volume":"13","author":"T Reimer","year":"2018","unstructured":"Reimer T, et al. Is Axillary Sentinel Lymph Node Biopsy required in patients who undergo primary breast surgery? Breast Care (Basel). 2018;13(5):324\u201330.","journal-title":"Breast Care (Basel)"},{"issue":"6","key":"3493_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00432-007-0333-7","volume":"134","author":"A Kavallaris","year":"2008","unstructured":"Kavallaris A, Camara O, Runnebaum IB. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine. J Cancer Res Clin Oncol. 2008;134(6):667\u201372.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"3493_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/abm-2019-0046","volume":"13","author":"M Vongsaisuwon","year":"2019","unstructured":"Vongsaisuwon M, Pongpirul K, Chatamara K. Clinical outcomes and surgical preferences for breast-conserving surgery and mastectomy: a propensity score-matched analysis. Asian Biomed. 2019;13(3):95\u2013100.","journal-title":"Asian Biomed"},{"issue":"6","key":"3493_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00000658-199906000-00013","volume":"229","author":"VS Klimberg","year":"1999","unstructured":"Klimberg VS, et al. Subareolar Versus Peritumoral Injection for Location of the Sentinel Lymph Node. Ann Surg. 1999;229(6):860.","journal-title":"Ann Surg"},{"issue":"1","key":"3493_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13193-020-01235-y","volume":"12","author":"C Malhotra","year":"2021","unstructured":"Malhotra C, et al. Efficacy of Periareolar Versus Peritumoral Injection of TC99-Labelled Sulphur Colloid and Methylene Blue Dye for Detection of Sentinel Lymph Node in patients with early breast Cancer: a comparative study. Indian J Surg Oncol. 2021;12(1):119\u201323.","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"3493_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jso.21308","volume":"100","author":"M Noguchi","year":"2009","unstructured":"Noguchi M, Inokuchi M, Zen Y. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol. 2009;100(2):100\u20135.","journal-title":"J Surg Oncol"},{"key":"3493_CR19","first-page":"37","volume":"12","author":"RV Yap","year":"2020","unstructured":"Yap RV, De La FM, Serna. Outcomes of Sentinel Lymph Node Biopsy using Blue Dye Method for early breast Cancer - A single-Institution experience in the Philippines. Breast Cancer (Dove Med Press). 2020;12:37\u201344.","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"3493_CR20","unstructured":"Skandalakis JE, Shiffman MA. 2009, Springer Berlin Heidelberg: Berlin, Heidelberg. 3\u201324."},{"issue":"5","key":"3493_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/ca.20812","volume":"22","author":"H Suami","year":"2009","unstructured":"Suami H, Pan WR, Taylor GI. Historical review of breast lymphatic studies. Clin Anat. 2009;22(5):531\u20136.","journal-title":"Clin Anat"},{"issue":"5","key":"3493_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/jpm14050464","volume":"14","author":"G de Moraes FCAd","year":"2024","unstructured":"de Moraes FCAd G, Alves VFC, Priantti JN, Gomes GC, Carnevalli SVB, Madeira T, Vilbert M, Stecca C, Figueroa Magalh\u00e3es MC, et al. Cyclin-dependent kinase 4\/6 inhibitors plus endocrine therapy versus endocrine therapy alone for HR-Positive, HER-2-Negative early breast Cancer: Meta-Analysis of Phase III randomized clinical trials. J Personalized Med. 2024;14(5):464. https:\/\/doi.org\/10.3390\/jpm14050464.","journal-title":"J Personalized Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03493-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T15:03:10Z","timestamp":1722697390000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03493-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03493-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was certified by the Institutional Review Board of the faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, has approved the study in compliance with the international guidelines for human research protection as declaration of Helsinki, The Belmont Report, CIOMS Guideline and International Conference on Harmonization in Good Clinical Practice (ICH-GCP). The certified Expedited Review approval is COA No. 1530\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}